Actively Recruiting

Phase Not Applicable
Age: 18Years - 55Years
All Genders
ID06107764

Cerebellar Modulation of Cognition in Psychosis

Led by Mclean Hospital · Updated on 2026-03-17

95

Participants Needed

2

Research Sites

N/A

Total Duration

On this page

Sponsors

M

Mclean Hospital

Lead Sponsor

B

Beth Israel Deaconess Medical Center

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are investigating cognition in psychotic disorders such as schizophrenia, bipolar disorder, and schizoaffective disorder. The study aims to understand if magnetic stimulation can influence processing speed, which reflects how quickly people solve challenging tasks. This research focuses on cognitive impairments that contribute to disability and poor quality of life, exploring a non-invasive method to temporarily alter brain activity. Participants will undergo different types of transcranial magnetic stimulation (TMS) including intermittent theta burst stimulation (iTBS), continuous theta burst stimulation (cTBS), and a sham (placebo) version. Each participant completes brain scans using magnetic resonance imaging (MRI) and cognitive testing before and after TMS sessions to observe changes in cognitive performance and brain circuits. The study uses these methods to compare the effects of the various TMS patterns on cognition. During the study, participants perform cognitive tasks and have MRI scans several times to measure brain activity and processing speed before and after each TMS session. The main outcomes measured include scores on cognitive tests such as the BACS Symbol Coding and BACS Digit Sequence tests, as well as functional MRI results. This study involves a randomized design with single masking and follows participants through multiple TMS visits to assess changes over time.

CONDITIONS

Brief Title

Cerebellar Modulation of Cognition in Psychosis

Who Can Participate

Age: 18Years - 55Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age between 18 and 55 years
  • Diagnosis of a psychotic disorder such as schizophrenia, schizoaffective disorder, or bipolar disorder type I
  • Able to read, speak, and understand English
  • Capable of completing study procedures as judged by study staff
  • In stable outpatient treatment with no hospitalizations or medication changes in the past 30 days
Not Eligible

You will not qualify if you...

  • Moderate substance use disorder diagnosis within the past month
  • Conditions increasing risk from rTMS or MRI, including:
  • Intracranial pathology from genetic or acquired neurological diseases
  • History of fainting spells that may indicate seizures
  • History of seizures or epilepsy
  • Progressive neurological disorders like multiple sclerosis or Parkinson's disease
  • Uncontrolled medical conditions that could cause emergencies during seizures
  • Presence of metal implants (except dental fillings) unless MRI-compatible joint replacements
  • Having a pacemaker, implanted medication pump, vagal nerve stimulator, deep brain stimulator, or transcutaneous electric nerve stimulation unit
  • Ventriculo-peritoneal shunt
  • Signs of increased intracranial pressure or intracranial lesions
  • History of head injury causing prolonged loss of consciousness or neurological complications
  • Pregnancy; pregnancy tests required for those who may become pregnant, and pregnant individuals will not enroll

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - Three visits spaced according to the study schedule

Participants undergo three separate visits where they receive different transcranial magnetic stimulation (TMS) interventions — intermittent theta burst stimulation (iTBS), continuous theta burst stimulation (cTBS), and sham rTMS — with cognitive testing and MRI scans before and after each TMS session.

3 visits (in-person)

Trial Site Locations

Total: 2 locations

1

McLean Hospital

Belmont, Massachusetts, United States, 02478

Actively Recruiting

2

Beth Israel Deaconess Medical Center

Boston, Massachusetts, United States, 02215

Actively Recruiting

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

OTHER

Number of Arms

3

Similar Trials

Effects of Multi-Session 40 Hz Visual Stimulation on Neurona...

Negative Symptoms in Schizophrenia

Actively Recruiting

1 location

A Randomized, Open-label, Multicenter, Two-formulation, Mult...

Schizophrenia

Actively Recruiting

1 location

A Multi-Center, Randomized, Double-Blind, Parallel-Design St...

Schizophrenia

Actively Recruiting

2 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here